← All companies
VTGN
Vistagen Therapeutics, Inc.
$0.25
+0.01 +2.08%
Key statistics
from XBRL data in SEC filingsMarket cap
$10.1M
Revenue (TTM)
$1.27M
Net income (TTM)
-$69.7M
EPS (TTM)
$-1.83
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$30.8M
Total assets
$48.6M
Gross margin
—
52-week range
$0.20 – $5.14
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Regulation FD disclosure
Jul 31, 2026
8-K
Regulation FD disclosure; Other events
Jun 30, 2026
8-K
Director or officer change
Jun 17, 2026
10-K
Fiscal year ended 2026-03-31
Jun 15, 2026
8-K
Results of operations (earnings release)
Jun 15, 2026
8-K
Other events
Jun 9, 2026
8-K
Director or officer change; Regulation FD disclosure
May 19, 2026
8-K
Other events
May 12, 2026
8-K
Other events
May 8, 2026
8-K
Other events
Apr 28, 2026
8-K
Director or officer change
Apr 13, 2026
8-K
Delisting notice or listing-rule failure
Apr 2, 2026
8-K
Director or officer change
Mar 18, 2026
8-K
Regulation FD disclosure
Mar 16, 2026
8-K
Other events
Mar 11, 2026
8-K
Director or officer change
Feb 20, 2026
10-Q
Quarter ended 2025-12-31
Feb 12, 2026
8-K
Results of operations (earnings release)
Feb 12, 2026
8-K
Delisting notice or listing-rule failure
Feb 6, 2026
8-K
Regulation FD disclosure
Jan 9, 2026
8-K
Other events
Dec 22, 2025
8-K
Director or officer change; Regulation FD disclosure
Dec 3, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Results of operations (earnings release)
Nov 13, 2025
8-K
Regulation FD disclosure
Nov 4, 2025
8-K
Director or officer change; Regulation FD disclosure
Oct 29, 2025
8-K
Director or officer change; Shareholder vote results
Sep 15, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 7, 2025
8-K
Director or officer change
Jun 25, 2025
8-K
Results of operations (earnings release); Other events
Jun 17, 2025
10-K
Fiscal year ended 2025-03-31
Jun 17, 2025
8-K
Regulation FD disclosure
Jun 2, 2025
8-K
Other events
Mar 6, 2025
10-Q
Quarter ended 2024-12-31
Feb 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 13, 2025
8-K
Other events
Feb 5, 2025
8-K
Other events
Jan 14, 2025
8-K
Other events
Jan 13, 2025
8-K
Regulation FD disclosure
Dec 6, 2024